1. Home
  2. SURG vs LSTA Comparison

SURG vs LSTA Comparison

Compare SURG & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$1.73

Market Cap

47.6M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.02

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
LSTA
Founded
2006
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
20.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SURG
LSTA
Price
$1.73
$2.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$9.75
$23.50
AVG Volume (30 Days)
135.2K
23.6K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,372,555.00
$1,070,000.00
Revenue This Year
$7.13
N/A
Revenue Next Year
$122.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$1.81
52 Week High
$3.47
$4.20

Technical Indicators

Market Signals
Indicator
SURG
LSTA
Relative Strength Index (RSI) 47.99 47.86
Support Level $1.58 $2.00
Resistance Level $1.90 $2.17
Average True Range (ATR) 0.19 0.10
MACD 0.05 0.02
Stochastic Oscillator 72.94 52.00

Price Performance

Historical Comparison
SURG
LSTA

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: